XML 18 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Unaudited Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net income $ 247,527 $ 204,634
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 16,500 16,509
Share-based compensation 11,769 9,599
Deferred income tax provision 3,925 4,101
Non-cash contribution to 401(k) plan 2,945 2,428
Other income from investment in unconsolidated entity (8,491) (2,294)
Other, net 927 103
Changes in operating assets and liabilities, net of effects of acquisition:    
Accounts receivable (126,181) (89,394)
Inventories (50,566) (97,685)
Accounts payable and other liabilities (23,286) 141,885
Other, net (5,004) (507)
Net cash provided by operating activities 70,065 189,379
Cash flows from investing activities:    
Capital expenditures (12,897) (13,829)
Business acquisition, net of cash acquired (5,828)  
Investment in unconsolidated entity (3,760) (63,600)
Proceeds from sale of property and equipment 143 139
Net cash used in investing activities (22,342) (77,290)
Cash flows from financing activities:    
Dividends on Common and Class B common stock (154,951) (119,468)
Repurchases of common stock to satisfy employee withholding tax obligations (3,782) (4,674)
Distributions to non-controlling interest (2,178) (6,799)
Net (repayments) proceeds of other long-term obligations (182) 41
Purchase of additional ownership from non-controlling interest   (42,688)
Net proceeds from the sale of Common stock   5,391
Proceeds from non-controlling interest for investment in unconsolidated entity 752 12,720
Net proceeds from issuances of common stock 5,979 3,115
Net proceeds under revolving credit agreement 94,600 49,406
Net cash used in financing activities (59,762) (102,956)
Effect of foreign exchange rate changes on cash and cash equivalents (845) 1,524
Net (decrease) increase in cash and cash equivalents (12,884) 10,657
Cash and cash equivalents at beginning of period 80,496 56,010
Cash and cash equivalents at end of period 67,612 $ 66,667
Supplemental cash flow information:    
Common stock issued for Alert Labs Inc. $ 8,180